Viewing StudyNCT00126646



Ignite Creation Date: 2024-05-05 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00126646
Status: COMPLETED
Last Update Posted: 2010-06-22
First Post: 2005-08-02

Brief Title: BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia Prolymphocytic Leukemia or Non-Hodgkins Lymphoma
Sponsor:
Organization: MedImmune LLC